Purple Biotech (PPBT) Interest Expenses (2014 - 2026)
Purple Biotech (PPBT) reported Interest Expenses of $31000.0 for Q1 2026, down 11.43% year-over-year from $35000.0 in Q1 2025, and down 85.51% quarter-over-quarter from $214000.0 in Q4 2025.
Purple Biotech (PPBT) Interest Expenses (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 12 years of Interest Expenses data on file, last reported at $31000.0 in Q1 2026.
- Interest Expenses for Q1 2026 came in at $31000.0, down 11.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $230000.0 (down 54.09% YoY), and the FY2025 annual result was $982000.0, up 103.31% from the prior year.
- Interest Expenses slipped to $31000.0 in Q1 2026 per PPBT's latest filing, from $214000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $2.1 million in Q4 2023 and troughed at -$859000.0 in Q2 2022.
- A 5-year average of $133882.4 and a median of $24000.0 in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2023: Interest Expenses slumped 942.16% in 2022, then soared 11505.56% in 2023.
- A 5-year view of Interest Expenses shows it stood at $18000.0 in 2022, then soared by 11505.56% to $2.1 million in 2023, then sank by 103.3% to -$69000.0 in 2024, then jumped by 410.14% to $214000.0 in 2025, then sank by 85.51% to $31000.0 in 2026.
- Business Quant data shows PPBT's Interest Expenses at $31000.0 in Q1 2026, $214000.0 in Q4 2025, and $5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -5.58 Mn |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - | 31,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | 214,000.00 |
| Dec 31, 2025 | 214,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | -69,000.00 |
| Dec 31, 2024 | -69,000.00 |
| Sep 30, 2024 | 511,000.00 |
| Sep 30, 2024 | 511,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 2.09 Mn |
| Dec 31, 2023 | 2.09 Mn |